MedPath

Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis

Not Applicable
Completed
Conditions
Ulcerative Colitis
Pouchitis
Registration Number
NCT06316999
Lead Sponsor
Mayo Clinic
Brief Summary

Intestinal ultrasound (IUS) has been studied in the evaluation of inflammatory bowel disease (IBD) and is increasingly used as a non-invasive, easy to use, cost-effective tool for point-of-care to assess disease activity and more recently to predict response to treatment. However, there is a paucity of data on the use of IUS specifically for ulcerative colitis (UC) patients with an ileal pouch-anal anastomosis (IPAA).

Detailed Description

AIMS:

1. Establish normal sonographic parameters in patients with an IPAA and normal pouch function.

2. Evaluate the feasibility of IUS for diagnosing pouchitis and other outcomes and compare its performance with the current gold standard of pouchoscopy with biopsies.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
55
Inclusion Criteria
  • Adults (age ≥ 18 years)
  • Diagnosis of ulcerative colitis (UC)
  • Status post ileal pouch anal anastomosis IPAA (completed all stages)
Exclusion Criteria
  • Pediatric patients
  • Indeterminate colitis
  • Status post IPAA for familial adenomatous polyposis (FAP)
  • BMI > 30 kg/m2
  • Pregnant
  • Decompensated Cirrhosis
  • Inability to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Diagnostic accuracy of intestinal ultrasound (IUS) for pouchitisthrough study completion, an average of 1 year

compared to gold standard of pouchoscopy with biopsies

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

Mayo Clinic
🇺🇸Rochester, Minnesota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.